Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Thure Meyer who wrote (958)	3/25/1999 6:42:00 PM
From: Instock	Read Replies (1) \| Respond to of 1837

Thure: DRMD and a Marking agreement with Warner-Lambert is the rumor I have seen kicked around on several Message / Chat Websites today. Could very likely be anyone, but Warner - Lambert's name seems to keep coming up. I would not be surprised to see the Stock Gap Up again tomorrow, and Run Strong UP to the time that the CEO appears on CNBC. 11:00 Am In the Interview, that would be an excellent time to either pre announce a Marketing Agreement or at least give further Hint/details then what todays Press release had to say. There is always that possablity that the company will have Another Press release friday. THAT whould be icing on the cake!! Any Targets for tomorrow? I would like to see the stock make a hard run on todays high. The $17 range. Break that, and who knows where the stock will end up...IMO Instock

To: Thure Meyer who wrote (958)	3/25/1999 8:17:00 PM
From: harkenman	Read Replies (1) \| Respond to of 1837

I am surprised on the extent of your research. J & J is the marketing partner. DRMD is currently the provider of estropipate (Ortho-Est) for Ortho Pharmaceutical. Estropipate is a synthetic salt form of estrone sulfate a component of conjugated estrogens. Ortho (a J&J subsidiary) is the number 1 distributor of hormone therapy products (birth control, HRT). Ortho bankrolled DRMD during the early 90's as evidenced by the SEC filings. Check the news in the next days when it becomes public.